Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses (Website, Publication)Nature
10 May 2020
Saunders, K.O., Lee, E., Parks, R. et al.
Global Variants Report (Covid Data Tracker) (Updated weekly) (NEW 5/4, Website, Regulatory)CDC
Maps and a list of countries that have reported variants of SARS-CoV-2.
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021 (Website, Publication)CDC / MMWR
30 April 2021
MacNeil JR, Su JR, Broder KR, et al.
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients
Linked Clusters of SARS-CoV-2 Variant B.1.351 — Maryland, January–February 2021 (Website, Publication)CDC/MMWR
30 April 2021
Feder KA, Pearlowitz M, Goode A, et al.
FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines (NEW 4/28, Website, Regulatory)FDA
21 April 2021
During an inspection of Emergent BioSolutions that ended Tuesday, the FDA cited a number of observations concerning whether the facility’s processes met FDA requirements and standards.